Florida, Lorna P.

HRN: 21-30-48  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2022
CEFUROXIME 1.5GM (VIAL)
04/30/2022
04/30/2022
IVT
1.5gm
IVT Now ANST As LD
UTI; Pus Cells: 10-15
Waiting Final Action 
04/30/2022
CEFUROXIME 750MG (VIAL)
04/30/2022
05/06/2022
IVT
750mg
Q8
UTI; Pus Cells: 10-15
05/02/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/02/2022
05/08/2022
IVT
3g
Q6hours
S/P Tahbs, Unspecified Sepsis
Waiting Final Action 
05/02/2022
DOXYCYCLINE 100MG (CAP)
05/02/2022
05/08/2022
PO
100mg
BID
SP TAHBS, Unspecified Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: